WeVote
Log In

Bill

Bill

HB 2437

Establishing fee authority for accreditation services provided to opioid treatment programs by the department of health.

2025-2026 Regular Session Introduced by Lauren Davis and 8 co-sponsors

Bill authorizes Washington Department of Health to charge opioid treatment programs fees for state accreditation services to fund regulatory oversight.

Referred to Appropriations.
0
WeVote Research Nonpartisan
Bill Summary · HB 2437

Legislative bill overview

HB 2437 authorizes the Washington Department of Health to establish and collect fees from opioid treatment programs (OTPs) in exchange for accreditation services. Currently, the department provides accreditation oversight without a dedicated fee mechanism, and this bill creates the authority to charge programs for this regulatory service.

Why is this important

Opioid treatment programs are heavily regulated healthcare facilities that require state oversight and accreditation. Creating a fee structure could generate revenue to fund the department's accreditation activities, potentially improving inspection frequency and quality assurance. Alternatively, fees could increase operational costs for treatment providers, which may be passed to patients or insurers.

Potential points of contention

  • Cost burden on treatment access: Fees imposed on OTPs could increase their operational expenses at a time when affordable opioid treatment access is a public health priority, potentially limiting patient access in underserved areas
  • Fee structure uncertainty: The bill grants authority to establish fees without specifying the amount, methodology, or caps, raising concerns about potential overcharging or lack of transparency in how costs are calculated
  • Equity considerations: Smaller or rural treatment programs may face disproportionate burden from flat fees, while well-resourced urban programs absorb costs more easily, potentially widening healthcare disparities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.